Some pharmacies put Pfizer’s anti-new crown drugs on the shelves, which lasted for half a day; Tata Group’s $90 billion local investment plan

Original link: https://www.latepost.com/news/dj_detail?id=1425

Some pharmacies put Pfizer’s anti-new crown drug on the shelves, which lasted for half a day

According to Yicai.com and Jiemian News, the internet hospital under 1 Yaowang began pre-selling Pfizer’s new crown oral drug ritonavir tablets (Paxlovid) on December 13. Azvudine, a domestically produced new crown oral drug, will also be available for online sale.

Among them, the pre-sale price of Paxlovid is 2980 yuan/box. In the afternoon, it was reported that buyers need to obtain a prescription based on a positive result of the new coronavirus nucleic acid or antigen, and then purchase the medicine. However, according to the Red Star Capital Bureau, Paxlovid was no longer found on 1 Yaowang on the evening of the 13th. The platform told the 21st Century Business Herald that the media’s earlier interpretation of the online sales of the drug was inaccurate.

1 Yaowang issued a statement on the evening of the 13th: In accordance with the “Notice on Improving New Coronary Pneumonia Internet Medical Services” issued by the Office of the Prevention and Control Mechanism of the State Council on December 12, 2022, Internet hospitals will provide qualified patients with diagnosis, treatment and medication services .

  • Paxlovid is one of the designated antiviral drugs in the Ninth Edition of China’s New Crown Prevention and Control Program, which is applicable to “adults and adolescents (12 to 17 years old, weighing at least 40 kg)”.
  • According to the Chinese instructions of Paxlovid provided by Pfizer, the adverse reactions of the drug include diarrhea, taste perversion, indigestion, etc., and there are very strict contraindications, and it is forbidden to use it in combination with various analgesics, antiarrhythmics, and antipsychotics.
  • Please visit the following website for detailed instructions (adverse reactions and contraindications from the fourth page): https://ift.tt/OVreyc1

Another batch of cities adjusted epidemic prevention measures on December 13:

  • The Beijing Bureau of Culture and Tourism announced that it will resume group travel in Beijing and across provinces from now on. It has some pre-requirements for travel agencies: before the start of the trip, the temperature of tourists, tour guides, drivers and other participants in the group will be measured, and those with abnormal body temperature will not be allowed to participate in the trip; Vehicles should wear masks at all times.
  • Guangxi cancels pre-measures such as cross-regional reporting, nucleic acid and health code inspections, but when entering special places such as nursing homes, welfare homes, medical institutions, childcare institutions, and primary and secondary schools, you must scan the Guangxi Health Code site code, and the nucleic acid negative certificate must be in Within 48 hours.
  • The Hong Kong Special Administrative Region announced that citizens traveling to the Macau Special Administrative Region and the Mainland no longer need to undergo nucleic acid testing at ports and airports starting from the 14th, and they only need to present a negative nucleic acid test certificate within 48 hours. The three-day “medical observation period” that prohibits visitors from entering Hong Kong from entering bars, restaurants and gyms will also be cancelled, and citizens will no longer need to scan “safe travel” (similar to the “place code” in the Mainland).

Tata Group’s $90 billion homegrown investment plan

Last week, Tata Group, India’s largest company, announced that it would invest $90 billion over the next five years to develop its own semiconductor industry.

Chairman Natarajan Chandrasekaran said that Tata’s ultimate goal is to build its own wafer manufacturing plant, but due to lack of experience, it will start from the more back-end packaging and testing business, and it is expected to cooperate with the United States, Japan, China Cooperation with mature fabs in Taiwan and other places.

As early as June this year, Tata announced that it would work with Renesas, a Japanese automotive chip manufacturer, to jointly develop automotive semiconductors and components. Last month, Tata was also rumored to be buying a factory in India of iPhone assembler Flextronics. Its subsidiary has recently obtained the distribution rights of Apple in India, and will open 100 Apple stores in India in the future.

Tata is India’s most valuable and profitable company, with a history dating back to 1868 in colonial India. Today, its business covers dozens of fields, including tea, salt, steel, automobiles, aviation, software, electricity, and chemicals. The total number of employees exceeds 1 million. The only companies in the world that employ more people are Amazon and Walmart.

In the past few decades, Tata has been the most active company in India to participate in globalization. It has successively acquired the European steel giant Corus, the world’s second largest tea brand Tetley, and the automobile brand Jaguar Land Rover , and brought Starbucks to India in 2011.

Today, Tata is abandoning the strategy of the past and turning fully to the local market. In addition to its ambitious semiconductor plans, Tata has poured $1 billion into foundry electronics, $5 billion in power batteries and $350 million in the troubled Air India. Tata is also spending $2 billion on an app called Neu, which it hopes will connect users to Tata’s retail, hotel, car and other products.

According to “The Economist” magazine, Tata’s annual capital expenditure will increase to 18 billion US dollars, which is more than double the average level of the past decade, and 77% of the new investment will be concentrated in India. In this way, it became the largest investor in India.

The new opportunities brought about by the migration of global supply chains and the energy revolution, as well as the support of the Modi government, are important reasons for Tata to bet on the local market. India’s own abundant market and cheap labor also support Tata’s ambition to invest more in manufacturing. Last year, nearly 40% of Tata’s revenue came from India, and the growth rate of domestic revenue in the past decade is nearly twice that of overseas. (Qiu Hao)

U.S. inflation remains high, but rises less than Wall Street expects

In November, the U.S. Consumer Price Index (CPI) rose 7.1% year-on-year and 0.1% month-on-month. The core CPI excluding food and energy rose 6% year-on-year and 0.2% month-on-month. Several sets of data were lower than previous market expectations.

Futures contracts corresponding to the Dow Jones Industrial Average, the Nasdaq and the S&P 500 jumped at least 2%.

The increase in the price index is one of the “anchors” for the Fed to raise and lower interest rates. The simple logic is to raise interest rates to curb high inflation and prevent the economy from overheating, while lowering interest rates is the opposite. Wall Street’s concern is that if the price index rises more than 7.2% in November, it may “stimulate” the Fed to raise interest rates faster and more vigorously.

From 2012 to 2019, the month-to-month year-on-year growth rate of US CPI and core CPI did not exceed 3%. Research Affiliates reviewed the journey of 14 advanced economies back to “normal” from high inflation in the past 52 years: from CPI growth of more than 8% to 3%, the shortest was six years, the longest was twenty years, and the median was ten years. (Gong Fangyi)

FTX Founder Arrested, Binance Faces Charges, Crypto Resurgence

Recently, the encryption industry has experienced another storm. On December 12, SBF, the founder of the cryptocurrency exchange FTX, was arrested in the Bahamas on criminal charges brought by the US Department of Justice and has been charged by the US Securities and Exchange Commission (SEC) with defrauding investors.

The SEC statement alleges that SBF “orchestrated a years-long fraud” by concealing the transfer of FTX client funds to Alameda Research, which it personally controlled.

  • Note: See https://ift.tt/kgm81Kh for the SEC statement

The asset security of Binance, the world’s largest cryptocurrency exchange, has also been questioned. It released a report from the audit firm Mazars last week, but this report did not fully show Binance’s internal financial situation, nor did Mazars issue an opinion.

In addition, according to media reports, Binance has been under criminal investigation by the US Department of Justice for 4 years. The investigation charges include undocumented money transfers, conspiracy to launder money and violation of criminal sanctions. Zhao Changpeng and other executives have become the subject of investigation, and prosecutors have not yet made a final charge decision.

Affected by this, blockchain intelligence platform Nansen data shows that within 24 hours on December 12, Binance’s net outflow reached 902 million US dollars, exceeding the sum of all other exchanges’ net outflows.

In addition to the declining trust in the cryptocurrency industry, the Federal Reserve continues to raise interest rates to tighten monetary policy and rising interest rates have made Bitcoin less attractive. With the bankruptcy of companies such as Celsius and BlockFi that provide investors with high interest rates, the mounting losses have also made investors afraid to hold Bitcoin.

The price of Bitcoin has fallen to $17,000, down 75% from its all-time high. At the beginning of this month, Mark Mobius, who successfully predicted that Bitcoin will fall below $20,000 this year, said that it is expected that the price of Bitcoin will fall by 40% next year to below $10,000. (intern Zeng Xing)

Shares of Chinese semiconductor makers move on rumors

Today, the semiconductor sector of the Hong Kong stock market suddenly rose in late trading. As of the close, the two major fabs, SMIC and Hua Hong Semiconductor, rose by more than 9% and 17%, respectively. The stock price change may be related to a market rumor: China will formulate a semiconductor subsidy plan of over 1 trillion yuan, most of which will be used to subsidize fabs to purchase domestic equipment, which may be implemented as early as the first quarter of next year.

We have seen that executives of domestic equipment companies have reprinted relevant information on social media.

The news comes as the Netherlands and Japan consider cooperating with U.S. controls on semiconductor exports to China. At present, the Netherlands and Japan have agreed in principle. China has filed a complaint with the WTO over the U.S. controls.

Building a new fab or expanding a production line costs billions of dollars, about 80% of which is spent on equipment. Calculated by revenue ranking, among the top ten semiconductor equipment companies in the world, three are from the United States, five are from Japan, and two are from the Netherlands. Among them, key front-end equipment such as lithography machines are almost monopolized by these companies.

The purpose of U.S. export controls is to restrict China from making advanced chips, so in theory Chinese fabs can still buy less advanced equipment from overseas. But a shift towards supply autonomy is afoot.

According to public procurement and bidding information, from January to November this year, the winning rate of domestic equipment rose from 16% in 2020 to more than 30%. Huaxing Securities pointed out that the U.S. ban may force China to strengthen its emphasis on the development of mature processes, and increase the purchase of upstream domestic equipment and materials under cost pressure; currently, domestic equipment suitable for the 28nm process can cover 70% of the production process. But the penetration rate of domestic equipment is still below 20%. (Qiu Hao)

Canned yellow peaches, electrolyte water, what’s next?

With the changes in the epidemic prevention policy, people’s means of avoiding risks have also changed from hoarding food and vegetables to hoarding medicine and water. Even Hua Qingwen, ibuprofen, canned yellow peaches, electrolyte water, etc. were snapped up, and irrational behavior was accompanied by waves of panic. “Caixin” said that the antipyretics in the Hong Kong Special Administrative Region were out of stock, which may be related to purchasing agents and the resurgence of the local epidemic.

Buy medicines through regular channels without excessive hoarding.

With the increase in the number of new crown infections in various places, the increase in demand and the panic stockpiling, medicines such as ibuprofen and Tylenol in big cities are short-term out of stock. At the same time, a group of “strategies” appeared on the Internet, specifically teaching people how to stock up on medicines in third- and fourth-tier cities where the epidemic is not serious, and even in remote areas.

In these areas where medicines are still available, medical resources are scarce compared with big cities, and the replenishment capacity is also weaker. Although the epidemic has not yet spread to the local area, the spread of the virus does not distinguish between east, west, north and south. Statistics show that more than 75% of people in China catch a cold at least once a year.

Taking ibuprofen as an example, China has sufficient production capacity and high flexibility. The current supply gap caused by the surge in demand is temporary. Guo Yanhong, director of the Medical Emergency Department of the National Health Commission, clearly pointed out at the press conference, “There is no need to hoard and rush to buy drugs.” recommendations to choose alternative medicines.

  • Note: Peking Union Medical College Hospital’s new crown drug preparation suggestions: https://ift.tt/n6HIFQv

Electrolyte water has a certain effect, so don’t panic if you don’t buy it.

The importance of water to the human body is self-evident. Electrolytes dissolved in water are also important components of body fluids, mainly including potassium ions, sodium ions, chloride ions, etc., which together maintain the osmotic pressure balance, acid-base balance, and metabolism of body fluids. . Therefore, the discharge of water is also accompanied by the discharge of electrolytes. If you sweat too much or vomit or have diarrhea, you need to replenish electrolytes.

The “Guidelines for Home Rehabilitation Experts” issued by the Beijing Health Commission also mentioned “pay attention to water and electrolyte balance, and maintain a stable internal environment.”

But supplementing electrolytes doesn’t necessarily require an electrolyte drink. Fan Zhihong, associate professor of the Department of Nutrition and Food Safety, School of Food Science and Technology, China Agricultural University, said on Weibo that eating fruits, drinking porridge, tea, coconut juice, tomato soup, white radish and chicken soup can replenish the electrolytes lost by the human body. If there are no symptoms such as vomiting or diarrhea, you can eat normally and do not need to deliberately drink electrolyte water.

In the ingredients list of Alien Electrolyte Water, the sodium content is 20mg/100ml, which belongs to the “very low sodium beverage” in the national standard. Its product introduction shows that this product is an ordinary electrolyte drink, without any medicinal value or health care function, and the daily drinking amount is recommended not to exceed 3 bottles. The ingredient list of Pocari Electrolyte Powder includes white granulated sugar, anhydrous glucose, food flavor, etc.

You don’t have to buy yellow peaches for canned fruit.

The canned yellow peaches that were popular one step earlier have no medicinal effect. Some experts pointed out that yellow peach contains vitamin C, vitamin B family, β-carotene, etc., which are helpful to promote metabolism and improve immunity.

From the perspective of daily consumption, yellow peaches contain more sugar. For many people who have poor appetite due to colds and fevers, an appropriate amount of yellow peaches can replenish energy and boost appetite. Other canned fruits can also achieve similar results.

It is not advisable to eat when coughing. Cold food will cause some irritation to the airway and may aggravate the symptoms. In addition, the sugar in sweets can lead to bacterial growth, which can aggravate coughs caused by respiratory infections. (intern Zeng Xing)

OTHER NEWS

The number of domestic passenger flights recovered by 58%.

According to the data of Fei Changzhun, domestic passenger flights are expected to perform 6976 sorties on December 13, which is equivalent to 58.13% (12000) of the average daily flights in 2019. The low point of passenger flight volume after the end of the Shanghai epidemic in June occurred on November 29, with 2,592 flights carried out, only a fraction of the average daily number in 2019.

WeChat released “window advertisements” in Moments.

According to WeChat officials, WeChat Moments ads now support “window display”, which occupies one advertising space but can display three to four materials. For example, the main view is an advertisement for luxury bags, and the three small windows at the bottom can display other products of the same brand (such as accessories, clothing, shoes, etc.).

SpaceX plans to raise its valuation by 10%.

According to media reports, SpaceX recently plans to sell old shares at US$77 per share. According to PitchBook’s estimate, SpaceX’s valuation will reach US$140 billion, which is 10% more expensive than the US$127 billion in July.

The China Academy of Information and Communications Technology announced that it has deleted the data of the itinerary card.

In the announcement on the 13th, the China Academy of Information and Communications Technology mainly explained a few points: the user’s personal itinerary data will not be stored; the operation and maintenance data will be deleted and destroyed on a rolling basis. Click here to read the full announcement.

Goldman Sachs’ consumer business took another step back.

Sources said Goldman Sachs is considering cutting at least 400 jobs at its retail bank, a further loss of confidence in this long-sought new growth point. Behind it is the pressure of Goldman Sachs investment banking, brokerage and other main business income or profit reduction, and operating expenses increase. Analysts expect Goldman’s adjusted profit to fall 40 percent this year from a year earlier.

Extreme Krypton has submitted an IPO application and plans to raise US$1 billion.

It is expected to be listed in New York, USA as soon as the second quarter of next year, and the latest valuation may exceed US$10 billion. Media reports said the application was filed in secret, with the aim of hiding the details of the prospectus from other competitors as much as possible. In October this year, the monthly sales of Jikrypton’s first model, Jikrypton 001, exceeded 10,000 for the first time.

The largest acquisition in the pharmaceutical industry this year has come.

On December 12, global biopharmaceutical giant Amgen (Amgen) will acquire Horizon Therapeutics for US$27.8 billion. Horizon has a number of drugs for the treatment of eye diseases, rare diseases and inflammation. The acquisition will alleviate Amgen’s performance decline and patent expiration, but it will also push up its debt load. Amgen expects the deal to close in the first half of next year and begin accreting the company’s earnings in 2024.

Musk is no longer the richest man on earth.

As of 5:00 p.m. local time on Monday in the United States, Musk’s assets fell to about US$181 billion, giving up his position as the world’s richest man. The Bernard Arnault family, the real controller of LV parent company, replaced it with assets of more than 186 billion US dollars. Musk’s main wealth is the Tesla shares he holds, and the company has encountered some problems in production and sales this year, and because Musk mortgages or sells Tesla shares directly every time he wants to spend a lot of money, it is also difficult to a certain extent. It is dragging down the latter’s share price performance.

Boeing signed a US$10 billion airliner sales contract.

Boeing announced that United Airlines, one of the four major airlines in the United States, has agreed to buy 100 Boeing 787 aircraft and reserves the right to buy another 100. United needs to expand its fleet as it recently added more international flights as demand picks up. List prices for different variants of the Boeing 787 range from $248 million to $292 million. The actual transaction price is usually much lower than the list price.

This article is transferred from: https://www.latepost.com/news/dj_detail?id=1425
This site is only for collection, and the copyright belongs to the original author.